Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

Epithelial cell adhesion molecule (EpCAM) is overexpressed in 55%–75% of ovarian carcinomas (OC). EpCAM might be used as a target for a treatment of disseminated OC. Designed ankyrin repeats protein (DARPin) Ec1 is a small (18 kDa) protein, which binds to EpCAM with subnanomolar affinity. We tested...

Full description

Bibliographic Details
Main Authors:	Anzhelika Vorobyeva, Elena Konovalova, Tianqi Xu, Alexey Schulga, Mohamed Altai, Javad Garousi, Sara S. Rinne, Anna Orlova, Vladimir Tolmachev, Sergey Deyev
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	International Journal of Molecular Sciences
Subjects:	EpCAM radionuclide molecular imaging SPECT iodine PIB
Online Access:	https://www.mdpi.com/1422-0067/21/9/3310

Similar Items

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-10-01)

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
by: Sergey M. Deyev, et al.
Published: (2021-07-01)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
by: Tianqi Xu, et al.
Published: (2021-08-01)

On the prevention of kidney uptake of radiolabeled DARPins
by: Mohamed Altai, et al.
Published: (2020-02-01)

Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
by: Elena Shramova, et al.
Published: (2020-10-01)

Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE
by: Tomaž Žagar, et al.
Published: (2021-05-01)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01)

Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
by: Seyed-Ali Hosseinian, et al.
Published: (2018-08-01)

Evolution of Thyroglobulin Loop Kinetics in EpCAM
by: Serena H. Chen, et al.
Published: (2021-09-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
by: Vasanthakumar S, et al.
Published: (2017-07-01)

Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial‐mesenchymal transition
by: Xian Liu, et al.
Published: (2021-03-01)

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
by: Henrik Schinke, et al.
Published: (2021-04-01)

EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase
by: Takeshi Ouchi, et al.
Published: (2021-01-01)

Biology and clinical relevance of EpCAM
by: Laura Keller, et al.
Published: (2019-05-01)

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy
by: Maxim Rybalov, et al.
Published: (2014-04-01)

Current View on EpCAM Structural Biology
by: Aljaž Gaber, et al.
Published: (2020-05-01)

EpCAM- and/or NCAM-Expressing Hepatocellular Carcinoma in Which Behavior of Hepatic Progenitor Cell Marker-Positive Cells Are Followed
by: Atsunori Tsuchiya, et al.
Published: (2019-03-01)

EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study
by: Christa A. M. van der Fels, et al.
Published: (2017-08-01)

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
by: Martowicz Agnieszka, et al.
Published: (2012-10-01)

EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer
by: Arijit Mal, et al.
Published: (2021-01-01)

Significance of EpCAM and TROP2 expression in non-small cell lung cancer
by: Pak Min, et al.
Published: (2012-04-01)

Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins
by: Chuan-Jin Wu, et al.
Published: (2020-04-01)

Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation
by: Koichi Hasegawa, et al.
Published: (2017-08-01)

Ultra-Sensitive Automated Profiling of EpCAM Expression on Tumor-Derived Extracellular Vesicles
by: Pouya Amrollahi, et al.
Published: (2019-12-01)

Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
by: Ting Lan, et al.
Published: (2020-09-01)

A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression
by: Yu Hu, et al.
Published: (2019-07-01)

Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
by: Takehiro Hayashi, et al.
Published: (2017-10-01)

EpCAM proteolysis: new fragments with distinct functions?
by: Ulrike Schnell, et al.
Published: (2013-03-01)

Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation
by: Hasegawa, Kouichi
Published: (2018)

EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
by: Li Y, et al.
Published: (2017-08-01)

CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
by: Anna Torres, et al.
Published: (2019-04-01)

EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
by: Warangkana Chantima, et al.
Published: (2017-12-01)

Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells
by: Gaku Nakato, et al.
Published: (2020-08-01)

Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment
by: Afroditi Nanou, et al.
Published: (2019-08-01)

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
by: Sara S. Rinne, et al.
Published: (2020-02-01)

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis
by: Liang Zeng, et al.
Published: (2019-08-01)

Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines
by: Stefan Schönberger, et al.
Published: (2020-05-01)

Immunocyte Profiling Using Single-Cell Mass Cytometry Reveals EpCAM+ CD4+ T Cells Abnormal in Colon Cancer
by: Ting Zhang, et al.
Published: (2019-07-01)

Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion
by: Narendra V. Sankpal, et al.
Published: (2021-05-01)

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study
by: Anna K. Campos, et al.
Published: (2016-09-01)

Cannot write session to /tmp/vufind_sessions/sess_3hicac2ntn8046fqbcl1cckub0